You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復宏漢霖(02696.HK)與復星醫藥產業訂立復星醫藥產業技術服務協議

格隆匯3月16日丨復宏漢霖(02696.HK)公吿,於2022年3月16日,公司與復星醫藥產業訂立復星醫藥產業技術服務協議,據此,公司同意就由復星醫藥產業正在開發的一種抗體藥物FS2101向復星醫藥產業提供CMC及臨牀前毒理學研究服務。

根據復星醫藥產業技術服務協議,公司同意就一種復星醫藥產業正在開發的抗體藥物FS2101向復星醫藥產業提供CMC及臨牀前毒理學研究服務(包括細胞株開發、工藝開發、non-GMP樣品製備及cGMP生產準備、臨牀前生物分析及毒理學研究等),以支持復星醫藥產業完成符合國家藥監局及美國食品藥品管理局要求的臨牀試驗申請及臨牀試驗相關工作。

監於公司可以承接從工藝開發到動態藥品生產管理規範(cGMP)生產的CMC技術服務、分析檢測服務、臨牀前毒理學研究及生物分析服務工作,本次與復星醫藥產業進行技術服務的合作,將有助於為集團創造商業利益,故董事認為訂立復星醫藥產業技術服務協議乃對本公司有益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account